Sunbelt Securities Inc. acquired a new stake in Solventum Co. (NYSE:SOLV – Free Report) in the second quarter, HoldingsChannel reports. The firm acquired 7,792 shares of the company’s stock, valued at approximately $412,000.
Several other institutional investors and hedge funds have also modified their holdings of SOLV. Northwestern Mutual Wealth Management Co. purchased a new stake in Solventum in the 2nd quarter worth approximately $568,000. Creative Planning acquired a new stake in shares of Solventum during the second quarter worth $1,584,000. Bontempo Ohly Capital Mgmt LLC purchased a new stake in shares of Solventum in the second quarter valued at $299,000. Mackenzie Financial Corp acquired a new position in shares of Solventum during the 2nd quarter valued at about $2,253,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Solventum during the 2nd quarter worth about $4,537,000.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on SOLV. BTIG Research assumed coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating on the stock. Wolfe Research assumed coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. Argus initiated coverage on shares of Solventum in a research report on Monday, June 24th. They set a “hold” rating for the company. Wells Fargo & Company lowered their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating for the company in a research note on Friday, August 9th. Finally, The Goldman Sachs Group lifted their price objective on shares of Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research note on Monday, August 12th. One equities research analyst has rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $58.25.
Solventum Trading Down 3.5 %
Solventum stock opened at $67.30 on Wednesday. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.31 and a quick ratio of 0.96. The firm’s 50 day simple moving average is $63.22.
Solventum (NYSE:SOLV – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.10. The firm had revenue of $2.08 billion during the quarter, compared to the consensus estimate of $2.05 billion. Solventum’s quarterly revenue was up .2% compared to the same quarter last year. On average, analysts forecast that Solventum Co. will post 6.38 earnings per share for the current year.
Solventum Profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
- Five stocks we like better than Solventum
- Learn Technical Analysis Skills to Master the Stock Market
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is a buyback in stocks? A comprehensive guide for investors
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Ride Out The Recession With These Dividend KingsĀ
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLV – Free Report).
Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.